Colchicine in Patients with Chronic Coronary Disease
2020 · New England Journal of Medicine · 1,939 citations
https://doi.org/10.1056/nejmoa2021372
W
Willem A. Bax
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
5.3K
Citations
28
h-index
51
i10-index
Willem A. Bax is an academic researcher from Çevre, Şehircilik ve İklim Değişikliği Bakanlığı. The author has contributed to research in topics: Nitric Oxide and Endothelin Effects & Inflammasome and immune disorders & Atherosclerosis and Cardiovascular Diseases. The author has an h-index of 28, co-authored 73 publications.
ORCID: 0000-0002-2177-1475Papers by this author
worksColchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy
2021 · Atherosclerosis · 60 citations
https://doi.org/10.1016/j.atherosclerosis.2021.08.005
Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial
2022 · International Journal of Cardiology · 30 citations
https://doi.org/10.1016/j.ijcard.2022.12.026
The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial
2022 · Clinical Drug Investigation · 18 citations
https://doi.org/10.1007/s40261-022-01209-8
An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual Risk
2023 · Clinical Therapeutics · 18 citations
https://doi.org/10.1016/j.clinthera.2023.08.016
Prediction Models for Future High-Need High-Cost Healthcare Use: a Systematic Review
2022 · Journal of General Internal Medicine · 15 citations
https://doi.org/10.1007/s11606-021-07333-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat